# Nosopharm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nosopharm

- Industry: Biotechnology
- Headquarters: Nimes, France
- Website: www.nosopharm.com
- Total disclosed funding: $4.6M
- Latest round: Series B (Sep 14, 2020)
- Investors on record: 3

## About

Founded in 2009 and based in Nimes, France, Nosopharm SAS is a biotechnology company that develops new molecules to combat bacteria and pathogens with multiple drug resistance.

## Funding rounds

- Series B, Sep 14, 2020, $1.9M — Auriga Partners, Rhone-Alpes Creation
- Series A, May 24, 2017, $2.6M — Auriga Partners, Eiffel Investment Group, Rhone-Alpes Creation

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series B
- Eiffel Investment Group (https://capitalatlas.ai/funds/eiffel-investment-group) — Series A
- Rhone-Alpes Creation (https://capitalatlas.ai/funds/rhone-alpes-creation) — Series A, Series B